HomeInsightsEPS

Astrazeneca Pharma India Ltd EPS

Astrazeneca Pharma India Ltd EPS

stocks purchased

₹ 1.0 Cr

Volume Transacted

(Jan 14, 2025)

stocks purchased

1.5 K

Stocks Traded

(Jan 14, 2025)

Last Updated on: Jan 14, 2025

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

EPS

₹ 51.49

Last updated on: Jan 14, 2025

Key Highlights

  • The Earning per Share of Astrazeneca Pharma India Ltd is ₹ 51.49 as of 14 Jan 25 .
  • The earning per share of Astrazeneca Pharma India Ltd changed from ₹ 21.54 to ₹ 16.37 over 6 quarters. This represents a CAGR of -16.72% .

Historical Earning per Share of Astrazeneca Pharma India Ltd

No data available

* All values are in

Company Fundamentals for Astrazeneca Pharma India Ltd

Market Cap

17,575 Cr

EPS

51.5

P/E Ratio (TTM) *

136.5

P/B Ratio (TTM) *

25.9

Day’s High *

7473.95

Day’s Low

6868.55

DTE *

0.0

ROE *

18.9

52 Week High

8139.85

52 Week Low

4050.15

ROCE *

23.9

Market Price of Astrazeneca Pharma India Ltd

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20257030.35
13 Jan 20257043.7
10 Jan 20256912.5
09 Jan 20257076
08 Jan 20256892.55
07 Jan 20257092.85
06 Jan 20257251.75
03 Jan 20257113.75
02 Jan 20257137.75
01 Jan 20257206.4

BlinkX Score for Astrazeneca Pharma India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

17,576

Asset Value

955

17.4 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Astrazeneca Pharma India Ltd5117,575
Sun Pharmaceuticals Industries Ltd464,24,382
Divis Laboratories Ltd691,59,224
Cipla Ltd571,16,943
Dr Reddys Laboratories Ltd631,11,588
Mankind Pharma Ltd511,10,215

Historical Market Cap of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Revenue of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical EBITDA of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Net Profit of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Astrazeneca Pharma India Ltd News Hub

News

Volumes spurt at Astrazeneca Pharma India Ltd counter

Happiest Minds Technologies Ltd, Campus Activewear Ltd, Cera Sanitaryware Ltd, ITI Ltd are...

Read more

30 Dec 2024 14:30

News

AstraZeneca gets CDSCO nod to import cancer drug, Lynparza

This approval establishes the use of Olaparib in combination with Durvalumab as a maintena...

Read more

26 Nov 2024 14:49

News

AstraZeneca Pharma gains on plan to launch COPD drug

Earlier, on 2 December 2023, the pharma company intimated about the receipt of import and ...

Read more

19 Nov 2024 12:11

News

AstraZeneca slumps as Q2 PAT slides 27% YoY to Rs 38 cr

Revenue from operations jumped 31.16% year on year (YoY) to Rs 408 crore in the quarter en...

Read more

14 Nov 2024 12:34

News

Astrazeneca Pharma India to announce Quarterly Result

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 1...

Read more

25 Oct 2024 16:11

News

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed b...

Read more

24 Sep 2024 08:54

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Astrazeneca Pharma India Ltd

What is the EPS of Astrazeneca Pharma India Ltd stock?

The Earnings Per Share (EPS) of Astrazeneca Pharma India Ltd is 51.49. An EPS is the amount of net income attributed to each share of a common stock.

How is Astrazeneca Pharma India Ltd EPS calculated?

The EPS of Astrazeneca Pharma India Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Astrazeneca Pharma India Ltd report its EPS?

Astrazeneca Pharma India Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Astrazeneca Pharma India Ltd EPS?

Factors that influence the EPS of Astrazeneca Pharma India Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Astrazeneca Pharma India Ltd EPS growth indicate future performance?

Yes, consistent growth in Astrazeneca Pharma India Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions